Fertility testing is Gloriousan area of medicine that isn't really covered by insurance—and hasn't yet seen much innovation from the tech world.
Modern Fertility is trying to change that. The startup wants to be the first to revamp the experience of fertility testing and revolutionize how women think about their own fertility in the years before they're ready to have children.
The key is Modern Fertility's $149 at-home testing kit. Like the lab tests ordered at doctor's offices, the kit measures up to 10 key fertility hormones. Customers do a finger prick and send four drops of blood into accredited labs, where the results are reviewed by physicians.
Users can then view their results online with explanations about what the different levels of each hormone and numerical fertility score actually mean.
"We believe information is the first step," said cofounder Afton Vechery. "Women everywhere should know this information."
Vechery, a former product manager at 23andMe with experience in health tech and private equity, and Carly Leahy, who developed health products like flu shot delivery at Uber, co-founded Modern Fertility in an effort to address what they see as a serious shortage and lack of options in fertility testing resources.
"Women everywhere should know this information."
"There are only 2,000 reproductive endocrinologists in the United States and each one can only handle so much demand," Vechery said. "We're able to deliver more value than a single one doctor ordering these."
At-home medical testing has emerged in the past few years as a hot area of investment, with startups selling a wide variety of kits that offer everything from blood testing to intestinal health information.
There are already a few other companies addressing fertility: Future Family and Everlywell both offer fertility tests. Celmatix focuses on using data and DNA to give fertility insights. Other startups mostly focus on devices like wearables and apps to help track fertility, not tools to test it. Modern Fertility's test comes in at the lowest price point.
A Modern Fertility customer could pay $149 to order an at-home fertility test that would let her know her fertility levels. That's compared to the traditional experience of going to a lab for tests and paying somewhere around $1,500 out of pocket.
These tests are available for pre-order right now in advance of a launch planned for the end of the year. But that $149 price could go up once the startup is up and running. Users don't submit their insurance information, since most insurance plans don't cover fertility testing.
With a much more low-cost, accessible way to test fertility, women could get a sense of their own hormone levels years before they're ready to have children—instead of hearing unexpected news when they're finally ready to start trying. Women could rely on these tests as a regular component of their healthcare and check fertility levels once a year, as hormone levels continue to change.
For women who are trying to have children, the test could serve as a first step before seeing a specialist.
SEE ALSO: Android users want to get pregnant, iPhone users avoid it, fertility app study showsThe Y Combinator startup just raised $1 million in a funding round led by First Round Capital. With that first round of funding, Vechery and Leahy plan to build out their team. The key next step is hiring a chief medical officer.
Modern Fertility isn't trying to change the science of these fertility tests—only the way they're taken. By reaching an entirely new population of customers—women who aren't actively trying to get pregnant—the startup says it can do this all at scale. That's why it can offer a $1,350 discount.
SEE ALSO: Mad about the tampon tax? Try a subscription boxAs startups working on women's health, menstrual health and other oft-ignored kinds of tech get more attention from investors in Silicon Valley, Modern Fertility is one that could really change an outdated industry.
Four generations of British royalty pose for Christmas pudding photosObama includes 'Old Town Road' in his favorite music of the yearThe best sleep tracking devicesThe 15 best true crime podcasts of 2020How to watch the Oscars 2023Washington state proposes new bill to protect child 'influencers''The Legend of Vox Machina's Killbox fight proves that friendship kicks assThe best pig accounts to follow on InstagramAfter widespread backlash, Hallmark will bring back the lesbian wedding adGoogle Bard: Leaked email asks reveals employees asked to help test the AI chatbotThe 'AntCannibalism is consuming pop culture. What does it all mean?'Quordle' today: See each 'Quordle' answer and hints for February 16Obama includes 'Old Town Road' in his favorite music of the yearThe best sleep tracking devices'Joker 2' first look: Lady Gaga and Joaquin Phoenix are caught in a bad romanceA ton of people googled Area 51 in 2019'Hello Tomorrow!' review: Billy Crudup sells us to the moon and backThe 10 worst dating trends of the decade, from 'orbiting' to 'breadcrumbing'Try 'the new Bing' ahead of the official launch. How to preview the AI Visit Our Holiday Pop The Morning News Roundup of November 26, 2014 Douglas Coupland on Marshall McLuhan by James Atlas The Morning News Roundup for November 20, 2014 Why Migraines are the Most Glamorous of Headaches Who Are These Future Rock Cabinet of Wonder Four Paintings by Neo Rauch On This Day, William Tell Shot an Apple Off His Son’s Head Squeaky Wheels Emily Dickinson’s Norway The Morning News Roundup for December 1, 2014 The Morning News Roundup for December 2, 2014 Notes on Oxford Dictionaries’ Word of the Year Listening to Paradise Lost Call Me Madam Pipi Announcing Our Windows on the World Contest The Morning News Roundup for November 13, 2014 Mark Strand, 1934–2014 A Penny Saved Is a Waste of Time